Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Newsletter
Tax Day, Open Skies and Toyota’s Legal Tactics
Tax Day inspires out an array of protests and demonstrations. The U.S. and EU signed an “Open Skies” agreement last month, which purportedly allows airlines…
Newsletter
Unions, New Taxes and GM Crops
Andy Stern is leaving his post as head of the Service Employees International Union. The Obama Administration may soon propose a Value Added Tax (VAT).
Newsletter
Liquor Licensing, Off-label Drugs and Fannie & Freddie
A new proposal in New York to set up a “medallion” system of liquor-licensing will serve as a compromise between wine retailers and grocery store…
Op-Eds
Short-Sighted Ban Endangers Food Supply
This week, the Senate may vote on an amendment to the FDA Food Safety Modernization Act that could undermine the integrity of the U.S.
News Release
New Study Shows Benefits of “Off-Label” Promotion for Patients, Doctors
New Study Shows Benefits of “Off-Label” Promotion for Patients, Doctors Court to Weigh In on Pharmaceutical Free Speech Washington, D.C.,…
Study
Truth or Consequences
The Benefits of Off-Label Drug and Device Promotion…